Chronic suppurative otitis media

H8_CHRON_SUPOTITIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H66.1, H66.2, H66.3 Hospital discharge: ICD-9 — 3821 Hospital discharge: ICD-8 — 3811 Cause of death: ICD-10 — H66.1, H66.2, H66.3 Cause of death: ICD-9 — 3821 2 out of 7 registries used, show all original rules.	2854
4. Check minimum number of events None	2854
5. Include endpoints None	2854
6. Filter based on genotype QC (FinnGen only)	2854

Control definitions (FinnGen only)

Control exclude: H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	H8_CHRON_SUPOTITIS
CONTROL_EXCLUDE	H8_MIDDLEMASTOID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H66[1-3]
HD_ICD_9	3821
HD_ICD_8	3811
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H66[1-3]
COD_ICD_9	3821
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chronic suppurative otitis media based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36319	15843	20247
Only index persons	29488	13262	16226
Unadjusted period prevalence (%)
Whole population	0.51	0.45	0.57
Only index persons	0.56	0.49	0.62
Median age at first event (years)
Whole population	11.18	15.82	7.08
Only index persons	10.85	15.70	6.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2854	1437	1417
Unadjusted period prevalence (%)	0.56	0.49	0.62
Median age at first event (years)	28.93	25.48	32.43

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2575: Matched controls
25742

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

277.5

323.0

338

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

1801.7

323.0

564

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

243.4

323.0

427

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

664.5

323.0

443

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

+∞

323.0

1252

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

+∞

323.0

470

H71

ICD-10 Finland

Cholesteatoma of middle ear

1889.9

323.0

321

H65.3

ICD-10 Finland

Chronic mucoid otitis media

369.3

323.0

376

H66.0

ICD-10 Finland

Acute suppurative otitis media

12.0

278.4

543

559

UDC00

NOMESCO Finland

Ear microscopy

8.7

218.9

511

710

H65.2

ICD-10 Finland

Chronic serous otitis media

498.0

188.8

186

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

24.4

181.3

262

119

H66.9

ICD-10 Finland

Otitis media, unspecified

8.8

178.9

412

548

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

+∞

164.3

156

Z01.1

ICD-10 Finland

Examination of ears and hearing

4.5

157.6

646

1772

4122

FHL

Tympanostomy (tympanic tube)

95.2

153.2

169

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

+∞

143.0

136

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

80.8

141.2

159

4141

FHL

Myringoplasty (also for reasons other than inflammation)

1367.1

134.6

130

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

28.7

125.2

172

DC1AD

NOMESCO Finland

Temporalbone CT

43.9

123.0

153

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

+∞

117.6

112

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.9

117.5

976

4504

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

4.9

115.3

418

982

DCD00

NOMESCO Finland

Myringoplasty

1147.1

113.5

110

EMB30

NOMESCO Finland

Adenotomy

11.4

113.4

221

211

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

+∞

106.0

101

DFF00

NOMESCO Finland

Pure tone audiometry

4.6

105.4

403

995

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

81.0

103.1

116

H70.1

ICD-10 Finland

Chronic mastoiditis

+∞

101.7

S02CA02

ATC

flumetasone and antiinfectives; otic

5.8

100.0

305

583

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

+∞

95.4

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

10.4

87.1

177

182

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.3

86.4

1437

9176

H60.3

ICD-10 Finland

Other infective otitis externa

11.0

85.2

168

163

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

+∞

82.7

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

+∞

81.7

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

3.0

80.9

557

2186

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

+∞

80.6

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

49.8

79.3

H74.1

ICD-10 Finland

Adhesive middle ear disease

781.1

77.7

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

+∞

76.4

H60.9

ICD-10 Finland

Otitis externa, unspecified

4.6

75.4

285

684

4144

FHL

Mastoidectomy or aticomastoidectomy

+∞

72.2

H65.0

ICD-10 Finland

Acute serous otitis media

14.1

71.2

124

H60.8

ICD-10 Finland

Other otitis externa

8.4

71.1

162

203

4150

FHL

Tympanoplasty (including for reasons other than inflammation)

361.9

71.0

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

+∞

70.1

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

13.5

69.4

123

TDA90

NOMESCO Finland

Removal wax from ear

16.7

67.1

109

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

232.6

66.5

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

15.1

61.0

103

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

6.4

60.9

167

275

3842A

ICD-9 Finland

Other disorders of tympanic membrane, Perforation of tympanic membrane

+∞

60.6

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.8

58.8

210

472

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

61.5

56.7

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

+∞

56.4

4451

FHL

Guitar cutting

7.0

55.6

143

215

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

+∞

55.4

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

22.0

55.1

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

3.8

53.2

243

688

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

116.5

53.0

DCD10

NOMESCO Finland

Tympanoplasty

528.3

52.7

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

+∞

51.2

4147

FHL

Radical surgery, cavity filling and middle ear and / or eardrum plastic

+∞

48.1

R5120

NOMESCO Finland

Preparation of an aid

6.2

47.0

131

220

J35.2

ICD-10 Finland

Hypertrophy of adenoids

6.3

46.0

126

207

4151

FHL

Reoperation for chronic otitis media

+∞

46.0

J01DA08

ATC

[U] cefaclor; oral

2.6

45.5

385

1655

H04

ICPC

Ear discharge

5.5

45.5

139

262

J01DA06

ATC

[U] cefuroxime; systemic

2.4

44.1

421

1932

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

49.1

44.0

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

+∞

43.9

R01AD08

ATC

fluticasone; nasal

2.0

42.1

699

4088

1450

FHL

Otomicroscopy

31.8

40.2

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

39.7

J01DA01

ATC

[U] cefalexin; systemic

1.7

39.1

1528

11764

J01MA02

ATC

ciprofloxacin; systemic

1.8

38.1

928

6164

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

+∞

37.6

H61.2

ICD-10 Finland

Impacted cerumen

3.4

37.5

195

610

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

37.3

322

1393

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

37.3

279

1112

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

5.1

36.6

119

241

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.8

36.6

165

460

J01CA04

ATC

amoxicillin; systemic

1.8

36.6

2041

17351

DEB30

NOMESCO Finland

Radical mastoidectomy

187.6

35.8

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

79.3

34.9

DFF15

NOMESCO Finland

Speech audiometry

3.7

32.6

150

426

DEA10

NOMESCO Finland

Attico-antrotomy

+∞

32.4

DGW00

NOMESCO Finland

Dilatation of eustachian tube

+∞

32.4

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.8

31.0

207

768

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.6

30.6

110

249

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

13.5

30.5

H02AB06

ATC

prednisolone; systemic

1.6

28.8

1074

7881

J35.8

ICD-10 Finland

Other chronic diseases of tonsils and adenoids

11.7

28.6

S02AA03

ATC

boric acid; otic

9.1

28.4

H01

ICPC

Ear pain/earache

2.2

28.1

310

1503

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.9

27.4

118

317

H92.1

ICD-10 Finland

Otorrhoea

62.7

27.0

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.8

26.4

176

652

4121

FHL

Tympanic puncture or parasentosis in general anesthesia or operating room

13.9

26.3

J01DB01

ATC

cefalexin; oral

1.6

26.1

1953

16895

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

263.1

25.7

J01FA10

ATC

azithromycin; systemic

1.6

25.6

1365

10834

38400

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta

+∞

25.0

H02AB04

ATC

methylprednisolone; systemic

2.0

24.7

338

1791

ZXA10

NOMESCO Finland

Bilateral

1.8

24.1

439

2586

R03AC02

ATC

salbutamol; inhalant

1.5

23.5

1210

9445

H60

ICD-10 Finland

Otitis externa

3.1

23.0

133

450

H95.8

ICD-10 Finland

Other postprocedural disorders of ear and mastoid process

+∞

22.9

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

22.6

240

1139

H92.0

ICD-10 Finland

Otalgia

2.8

22.6

149

547

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

3.5

22.5

107

313

H73.1

ICD-10 Finland

Chronic myringitis

+∞

21.9

H66

ICD-10 Finland

Suppurative and unspecified otitis media

3.9

21.9

238

J01FA09

ATC

clarithromycin; systemic

1.6

21.6

696

4831

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

7.4

21.4

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

21.4

464

2879

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

21.0

398

2368

RK520

NOMESCO Finland

13.5

21.0

DCW00

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

+∞

20.9

4146

FHL

Radical cutting (bridge broken)

+∞

20.9

ZXA00

NOMESCO Finland

Right side

1.6

20.8

608

4106

4111

FHL

Ear canal extension

110.9

20.6

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

12.6

20.3

3824A

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified suppurative otitis media

+∞

19.8

DEB00

NOMESCO Finland

Cortical mastoidectomy

+∞

19.8

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

+∞

19.8

J01FF01

ATC

clindamycin; systemic

1.6

19.7

580

3916

H29

ICPC

Ear symptom/complaint other

2.1

19.6

235

1175

4143

FHL

Atticotomy or atticoanthromy through the ear canal

201.4

19.6

H72

ICD-10 Finland

Perforation of tympanic membrane

46.3

19.2

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

19.0

605

4159

J01DC02

ATC

cefuroxime; systemic

2.5

18.8

148

604

J01AA02

ATC

doxycycline; systemic

1.5

18.6

1696

14612

DAX08

NOMESCO Finland

Fitting of hearing aid

2.8

18.6

119

432

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.8

18.5

118

427

J32.4

ICD-10 Finland

Chronic pansinusitis

5.7

18.4

H02AB07

ATC

prednisone; oral

1.8

18.3

317

1824

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.6

18.3

230

H60.4

ICD-10 Finland

Cholesteatoma of external ear

20.2

17.7

R03BA05

ATC

fluticasone; inhalant

1.7

17.7

424

2696

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

17.6

466

3050

RK320

NOMESCO Finland

7.2

17.5

R01AD09

ATC

mometasone; nasal

1.5

16.9

961

7485

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

16.9

178

843

R06AE07

ATC

cetirizine; oral

1.5

16.8

964

7519

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

16.7

530

3625

ZXA05

NOMESCO Finland

Left side

1.6

16.7

537

3688

R03CC02

ATC

salbutamol; systemic

2.0

16.7

210

1073

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

+∞

16.7

RK110

NOMESCO Finland

7.5

16.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

16.3

829

6302

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.7

16.1

192

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

15.9

387

2464

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

33.6

15.7

H72.1

ICD-10 Finland

Attic perforation of tympanic membrane

+∞

15.6

S02CA03

ATC

hydrocortisone and antiinfectives; otic

23.5

15.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

14.9

168

818

ZXD20

NOMESCO Finland

Day surgery

1.8

14.8

282

1671

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

150.8

14.5

H70.0

ICD-10 Finland

Acute mastoiditis

150.8

14.5

RK120

NOMESCO Finland

12.6

14.4

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

5.7

14.2

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.4

13.9

115

486

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

13.8

306

1893

RK420

NOMESCO Finland

17.6

13.8

R03BA02

ATC

budesonide; inhalant

1.6

13.7

373

2446

R03BB04

ATC

tiotropium bromide; inhalant

1.9

13.7

218

1215

R03AC12

ATC

salmeterol; inhalant

2.5

13.7

111

463

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.9

13.7

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

4.1

13.6

128

4741B

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]

5.1

13.6

DED00

NOMESCO Finland

Obliteration of cavity after partial excision of mastoid

+∞

13.5

38299

ICD-8 Finland

Unspecified otitis media with mastoiditis

+∞

13.5

4129

FHL

Other measure in this category

140.7

13.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.9

13.3

281

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.0

13.2

132

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.7

13.1

291

1805

J01MA12

ATC

levofloxacin; systemic

1.6

12.9

385

2578

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

12.7

583

4301

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

4.1

12.4

120

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

12.4

489

3494

50499

ICD-8 Finland

Deflected nasal septum

3.7

12.3

141

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

12.2

564

4164

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

6.4

12.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

12.1

193

1076

J47

ICD-10 Finland

Bronchiectasis

4.0

11.9

120

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

11.9

556

4108

J33.8

ICD-10 Finland

Other polyp of sinus

3.6

11.9

151

J35.1

ICD-10 Finland

Hypertrophy of tonsils

3.4

11.8

167

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.1

11.5

110

J20

ICD-10 Finland

Acute bronchitis

1.8

11.4

199

1145

R03DC03

ATC

montelukast; oral

1.6

11.3

328

2182

H71

ICPC

Acute otitis media/myringitis

3.9

11.2

117

4222

FHL

Endonasal etmoidectomy

7.3

11.2

D07AC01

ATC

betamethasone; topical

1.4

11.0

679

5276

R51.80

ICD-10 Finland

Headache

1.6

11.0

310

2048

J01DC04

ATC

cefaclor; oral

3.7

10.9

125

UDC10

NOMESCO Finland

Tympanoscopy

43.5

10.9

H69.0

ICD-10 Finland

Patulous Eustachian tube

15.5

10.8

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

7.6

10.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

10.6

429

3072

H83.1

ICD-10 Finland

Labyrinthine fistula

110.4

10.4

4148

FHL

Radical cutting and cavity filling

+∞

10.4

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

+∞

10.4

74900

ICD-8 Finland

Cleft palate and cleft lip, Cleft palate

32.6

10.3

S02AA30

ATC

antiinfectives, combinations; otic

2.3

10.3

427

H73.0

ICD-10 Finland

Acute myringitis

10.6

10.3

ZZG00

NOMESCO Finland

Graft of cartilage

23.4

10.2

49300

ICD-8 Finland

Asthma, bronchiale

2.9

10.2

210

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

10.2

332

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.7

10.2

213

1297

H70

ICPC

Otitis externa

3.3

10.1

155

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

3.5

10.0

130

RK290

NOMESCO Finland

10.1

10.0

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

10.0

870

7123

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

5.3

10.0

R03AC03

ATC

terbutaline; inhalant

1.6

9.9

281

1858

R4135

NOMESCO Finland

Rehabilitation for hearing problems

3.6

9.9

121

N02BE01

ATC

paracetamol; systemic, rectal

1.3

9.6

1889

17331

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

10.1

9.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

9.5

961

8029

Z2221

NOMESCO Finland

Medical doctor

1.4

9.4

580

4484

DCA40

NOMESCO Finland

Fat patching or other similar technique without opening of tympanic membrane

+∞

9.4

5251

FHL

Hypotension

+∞

9.4

DCB00

NOMESCO Finland

Excision of lesion of middle ear

+∞

9.4

EMB10

NOMESCO Finland

Tonsillectomy

1.9

9.4

131

700

4741A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PALATINAE]

6.9

9.3

M01AE02

ATC

naproxen; oral, rectal

1.3

9.3

1213

10488

4452

FHL

Tonsil surgery

2.5

9.3

284

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.7

9.3

224

ZXE00

NOMESCO Finland

One hour or less

1.3

9.2

822

6731

J01FA01

ATC

erythromycin; systemic

1.5

9.1

282

1901

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

9.0

553

4272

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

8.8

437

R01AD11

ATC

triamcinolone; nasal

1.7

8.8

168

995

L17

ICPC

Foot/toe symptom/complaint

1.4

8.8

511

3908

N02AX02

ATC

tramadol; systemic, rectal

1.3

8.7

819

6750

J01FA15

ATC

telithromycin; oral

1.7

8.7

181

1104

Q37.1

ICD-10 Finland

Cleft hard palate with unilateral cleft lip

50.1

8.7

4224

FHL

Endonasal anthrostomy

4.2

8.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

8.6

352

2519

R74

ICPC

Upper respiratory infection acute

1.3

8.5

605

4784

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

4.1

8.5

R03BB01

ATC

ipratropium bromide; inhalant

2.2

8.4

400

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

7.4

8.4

R06AX13

ATC

loratadine; oral

1.5

8.4

297

2060

3890A

ICD-9 Finland

Deafness, Conductive deafness

90.3

8.4

R01AD05

ATC

budesonide; nasal

1.8

8.4

144

828

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

4.9

8.4

1451

FHL

Otomicroscopy and paper place

+∞

8.3

A02BC02

ATC

pantoprazole; systemic

1.3

8.3

1282

11270

J45

ICD-10 Finland

Asthma

1.6

8.2

191

1201

Z3226

NOMESCO Finland

Physiotherapist

1.4

8.2

378

2774

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

8.1

123

679

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.1

722

5893

E000001

ATC

1.4

8.1

435

3279

J01FA06

ATC

roxithromycin; oral

1.3

8.1

776

6400

Q35.1

ICD-10 Finland

Cleft hard palate

22.1

8.0

H91.8

ICD-10 Finland

Other specified hearing loss

4.4

7.9

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

7.9

714

5835

R4110

NOMESCO Finland

Physiotherapy

1.4

7.9

509

3956

Z2446

NOMESCO Finland

Social worker

1.7

7.9

153

914

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

7.9

105

554

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.8

263

1807

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.8

855

7175

H60.1

ICD-10 Finland

Cellulitis of external ear

3.5

7.8

DCA30

NOMESCO Finland

Exploration of middle ear

45.1

7.7

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

45.1

7.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

7.7

121

677

T16

ICD-10 Finland

Foreign body in ear

4.1

7.7

R01AD12

ATC

fluticasone furoate; nasal

1.3

7.6

561

4449

H60.0

ICD-10 Finland

Abscess of external ear

6.2

7.5

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

7.5

434

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.3

7.4

107

H74.0

ICD-10 Finland

Tympanosclerosis

80.3

7.4

WX110

NOMESCO Finland

Local anesthesy

1.3

7.4

1506

13597

H02

ICPC

Hearing complaint

1.5

7.4

219

1460

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

7.4

140

830

H69.8

ICD-10 Finland

Other specified disorders of Eustachian tube

13.4

7.4

H68.0

ICD-10 Finland

Eustachian salpingitis

13.4

7.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

7.3

332

2427

Q89.34

ICD-10 Finland

Cartagena syndrome (immotile cilia)

+∞

7.3

H74.4

ICD-10 Finland

Polyp of middle ear

+∞

7.3

DEB35

NOMESCO Finland

Radical mastoidectomy with tympanoplasty

+∞

7.3

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.9

7.2

106

581

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

7.2

109

600

S02CA01

ATC

prednisolone and antiinfectives; otic

30.1

7.1

J06.80

ICD-10 Finland

Continuously repeating infections of a child

20.1

7.1

D01AC02

ATC

miconazole; topical

1.7

7.1

149

910

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.1

345

2553

E0000UV

ATC

1.3

7.0

810

6816

N05BB01

ATC

hydroxyzine; systemic

1.7

6.9

127

747

H61.8

ICD-10 Finland

Other specified disorders of external ear

3.6

6.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

6.8

372

2805

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

6.8

184

1204

Z97.8

ICD-10 Finland

Presence of other specified devices

5.7

6.7

RK530

NOMESCO Finland

16.7

6.7

4661A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchiolitis

16.7

6.7

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

2.1

6.7

349

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

6.7

251

1765

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

6.7

456

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

6.6

349

2616

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

6.6

537

4309

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

6.6

344

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

6.5

468

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.5

1200

10648

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

3.6

6.5

H27

ICPC

Fear of ear disease

3.3

6.5

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

6.4

264

1895

B01AB05

ATC

enoxaparin; parenteral

1.3

6.4

547

4419

M01AB05

ATC

diclofenac; systemic, rectal

1.2

6.4

1315

11799

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

8.2

6.3

ZXC10

NOMESCO Finland

Use of laser

2.5

6.3

181

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

6.3

2007

18907

R03DA04

ATC

theophylline; systemic, rectal

1.8

6.3

107

618

3811A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media

+∞

6.2

3858X

ICD-9 Finland

Other disorders of middle ear and mastoid

+∞

6.2

38200

ICD-8 Finland

Acute / Acute otitis media with mastoiditis

+∞

6.2

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

3.0

6.2

106

D07AC13

ATC

mometasone; topical

1.3

6.2

532

4299

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

6.2

257

1847

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

6.2

650

5394

R03AC13

ATC

formoterol; inhalant

1.8

6.1

517

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

6.1

166

1087

H81.3

ICD-10 Finland

Other peripheral vertigo

2.3

6.1

224

S06.0

ICD-10 Finland

Concussion

1.5

6.1

208

1437

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

6.0

205

1415

38798

ICD-8 Finland

Other disease of ear and mastoid process, Alii definiti

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

606

2571

2.72

93.67

2.7

1.7

—

(3000494) Fungus identified in Specimen by Culture

457

2464

2.02

37.36

1.8

1.4

—

(3042936) Bacteria identified in Isolate by Culture

491

3069

1.72

24.28

2.2

2.0

—

(42870588) Differential panel, method unspecified - Blood

982

7574

1.45

18.56

6.3

6.1

—

(3022096) Basophils/100 leukocytes in Blood

1227

10193

1.36

13.80

6.9

6.1

0.7

0.12

1137

9531

(3006504) Eosinophils/100 leukocytes in Blood

1259

10522

1.35

13.52

6.7

6.0

2.9

2.8

0.63

1171

9807

(3018010) Neutrophils/100 leukocytes in Blood

1278

10737

1.34

13.12

6.5

5.9

56.3

56.8

0.84

1190

10064

(3019069) Monocytes/100 leukocytes in Blood

1262

10583

1.34

13.12

7.0

6.3

8.6

0.05

1175

9928

(3002030) Lymphocytes/100 leukocytes in Blood

1296

10926

1.34

12.93

6.8

6.1

28.7

28.3

0.47

1200

10209

(3013115) Eosinophils [#/volume] in Blood

1352

11549

1.32

11.98

6.7

6.2

e9/l

0.2

1.56

1158

10132

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

363

2481

1.53

11.93

4.0

4.2

32.0

32.4

0.29

250

1675

(3006315) Basophils [#/volume] in Blood

1300

11165

1.30

10.59

6.5

5.9

e9/l

0.0

1.73

1107

9647

(3019198) Lymphocytes [#/volume] in Blood

1329

11485

1.29

10.18

6.4

5.9

e9/l

2.1

2.0

0.90

1150

10117

(3001604) Monocytes [#/volume] in Blood

1291

11136

1.29

9.95

6.5

5.9

e9/l

0.6

2.65

1099

9617

(3009445) Proteinase 3 Ab [Units/volume] in Serum

152

894

1.74

9.16

2.3

1.4

u/ml

6.0

17.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1024

8657

1.28

8.95

2.0

pmol/l

94.7

95.5

0.21

547

4561

(3013707) Erythrocyte sedimentation rate by Westergren method

1772

16086

1.27

8.34

4.3

4.0

mm/h

12.4

11.7

1.34

1624

14864

(3005322) IgE [Units/volume] in Serum or Plasma

211

1384

1.57

8.32

1.5

1.3

u/ml

477.1

252.9

0.79

200

1272

(3019225) pH of Specimen

292

2064

1.46

8.07

3.9

4.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1804

16496

1.25

7.58

7.6

7.3

u/l

79.0

79.6

0.18

1685

15519

(3028192) IgG subclass 2 [Mass/volume] in Serum

200

2.42

7.50

1.8

1.3

g/l

2.9

0.10

140

(3027135) IgG subclass 1 [Mass/volume] in Serum

200

2.42

7.50

1.8

1.3

g/l

6.1

6.9

1.18

139

(3024139) IgG subclass 3 [Mass/volume] in Serum

200

2.42

7.50

1.8

1.3

g/l

0.3

0.4

0.69

140

(4062490)

202

2.40

7.35

1.9

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

516

4106

1.31

6.89

4.3

3.8

ng/l

298.2

433.1

0.53

398

3126

(3011412) CD3 cells [#/volume] in Blood

209

2.32

6.84

2.5

2.4

e9/l

1.5

1.2

0.84

116

(3013826) Glucose [Moles/volume] in Serum or Plasma

1422

12755

1.23

6.77

5.2

4.8

mmol/l

6.7

0.44

1315

11857

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

152

980

1.58

6.50

4.8

5.0

mmol/l

24.6

0.01

141

924

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

453

3569

1.32

6.47

2.0

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1102

9662

1.23

6.43

6.7

6.2

mmol/l

1.2

0.47

973

8745

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

166

2.43

6.36

2.3

10.3

13.3

0.87

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

117

711

1.67

6.35

1.8

1.5

titre

132.1

177.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1427

12867

1.22

6.25

9.2

8.9

e9/l

4.1

0.12

1218

11216

(3023368) Bacteria identified in Blood by Culture

708

5937

1.26

6.17

4.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

561

4618

1.27

5.67

1.5

g/l

2.5

2.3

0.63

317

2804

(3005719) IgG [Mass/volume] in Serum or Plasma

230

1663

1.42

5.66

2.8

2.7

g/l

10.2

10.6

0.44

215

1507

(4010399)

206

1460

1.44

5.65

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1194

10650

1.21

5.64

7.4

6.8

mmol/l

1.2

0.49

1024

8987

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1234

11048

1.21

5.59

6.0

umol/l

11.2

12.0

1.58

1154

10438

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

152

2.39

5.55

2.4

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

321

2467

1.34

5.43

2.0

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

654

5505

1.24

5.42

3.9

4.1

89.4

88.6

0.34

637

5368

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

202

1442

1.43

5.34

4.7

4.4

mmol/l

1.6

1.7

0.11

152

1036

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

686

5815

1.24

5.32

3.6

3.2

ng/l

1656.2

1545.2

0.27

578

4963

(3024561) Albumin [Mass/volume] in Serum or Plasma

1047

9260

1.21

5.32

4.9

g/l

35.7

0.01

962

8584

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2349

22438

1.26

5.32

16.0

13.7

mg/l

23.3

24.1

0.54

1898

17544

(3024980) IgG subclass 4 [Mass/volume] in Serum

338

1.88

5.28

1.9

1.7

g/l

0.7

0.8

0.23

263

(3037467) Urinalysis macro (dipstick) panel - Urine

1654

15273

1.20

5.19

4.8

4.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

420

1.78

5.19

1.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

209

1512

1.41

5.14

4.7

4.3

kpa

5.2

5.1

0.49

195

1403

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

158

2.29

5.12

2.6

2.5

e9/l

0.2

0.11

131

(40768804) Tissue Pathology biopsy report

953

8389

1.20

5.02

2.0

2.1

—

(3009343) pH of Capillary blood

206

1494

1.41

5.00

4.8

4.4

7.4

0.18

176

(3037522) Nuclear Ab [Titer] in Serum

359

2836

1.30

5.00

1.3

titre

578.9

523.2

0.17

570

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

319

2480

1.32

4.99

2.0

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

2.87

4.92

2.2

2.5

e6/l

384.3

304.7

0.22

(3028026) IgM [Mass/volume] in Serum or Plasma

184

1315

1.43

4.86

1.6

1.9

g/l

1.3

1.4

0.18

168

1206

(3032080) INR in Blood by Coagulation assay

963

8509

1.20

4.83

9.3

9.2

inr

1.2

1.3

0.27

241

2486

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1580

14582

1.19

4.82

3.0

3.1

u/l

49.1

46.3

0.52

1474

13634

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

163

2.22

4.78

2.6

2.5

e6/l

606.9

561.4

0.18

132

(3022313) Gas panel - Capillary blood

160

1118

1.46

4.77

4.9

4.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

627

5323

1.23

4.74

2.9

2.7

umol/l

2389.5

5813.8

1.86

532

4627

(40761536) Microorganisms panel - Urine sediment

137

1968

0.68

4.63

4.8

3.8

—

(3052851) Hemolysis interference index of Serum or Plasma

100

636

1.59

4.63

3.5

3.3

—

(3017732) Neutrophils [#/volume] in Blood

194

1416

1.40

4.56

3.0

2.8

e9/l

4.1

0.05

141

1117

(1761868) Lipid panel - Serum or Plasma

648

7496

0.82

4.42

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

623

5322

1.22

4.40

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

363

2933

1.27

4.24

6.4

6.1

mmol/l

1.1

0.46

336

2716

(3044640) Blood type and Crossmatch panel - Blood

791

6933

1.19

4.24

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

213

1604

1.35

4.16

4.2

4.1

ng/l

102.0

87.3

0.62

187

1393

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

763

6678

1.19

4.14

2.6

2.5

u/l

57.1

57.0

0.01

706

6159

(3016244) Insulin [Units/volume] in Serum or Plasma

167

2.11

4.13

3.6

3.0

mu/l

27.5

26.6

0.05

155

(3010144) Erythrocytes [#/volume] in Synovial fluid

188

2.03

4.08

1.5

1.3

e6/l

193675.6

102677.8

0.29

132

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

258

1.87

4.08

1.8

2.2

mg/l

19.0

25.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

104

2.42

4.05

1.7

1.5

nmol/l

1.4

1.2

0.32

(3000475) Leukocytes [#/volume] in Synovial fluid

493

1.62

4.00

1.8

1.6

e6/l

20465.2

12499.9

0.36

357

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

562

4796

1.21

3.98

1.8

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

989

8891

1.17

3.86

2.4

2.3

nmol/l

75.5

75.9

0.15

875

7997

(21494815) CD4 cells/100 lymphocytes in Specimen

187

1.99

3.78

2.7

2.4

46.8

44.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

176

1308

1.37

3.76

3.7

3.3

pmol/l

4.5

0.47

146

1165

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2025

19267

1.18

3.71

5.8

5.4

mmol/mol

39.7

39.5

0.61

1866

17826

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

715

6282

1.18

3.66

2.1

2.2

u/l

218.6

241.9

0.25

658

5906

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

152

1110

1.39

3.62

9.2

9.6

mmol/l

24.4

24.3

0.07

140

1039

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

314

1.73

3.59

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

264

1.79

3.52

1.4

—

(3047181) Lactate [Moles/volume] in Blood

678

1.48

3.36

6.3

7.2

mmol/l

1.6

1.3

0.77

585

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

268

1.77

3.36

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.71

3.35

1.0

—

(3051651) Icteric interference index of Serum or Plasma

134

2.10

3.33

3.6

3.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

573

4988

1.19

3.24

1.6

1.5

nmol/l

19.0

20.2

1.30

488

4264

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

125

902

1.40

3.23

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

267

1.73

3.12

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

267

1.73

3.12

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

495

1.53

3.07

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

495

1.53

3.07

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

411

3489

1.21

3.06

1.3

1.2

iu/ml

24.5

31.9

1.12

115

1046

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

361

1.62

3.05

1.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.51

3.04

1.6

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

657

5815

1.17

3.02

2.4

2.2

mg/l

2.8

2.9

0.63

545

4933

(3004789) Transferrin [Mass/volume] in Serum or Plasma

377

3178

1.21

3.02

2.6

2.4

g/l

2.3

0.04

347

2935

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

292

2397

1.24

3.01

7.8

7.6

kpa

5.2

5.1

0.61

276

2275

(3027801) Oxygen [Partial pressure] in Arterial blood

292

2398

1.24

3.00

7.8

7.6

kpa

11.6

12.4

1.45

276

2278

(3025468) Yersinia sp identified in Specimen by Organism specific culture

263

1.72

2.99

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

263

1.72

2.99

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.41

2.96

2.0

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

264

1.72

2.96

1.4

—

(3003396) Base excess in Arterial blood by calculation

291

2394

1.24

2.95

7.8

7.6

mmol/l

0.9

1.1

0.30

225

1835

(3051611) Lipemic interference index of Serum or Plasma

220

1.78

2.93

3.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

523

0.53

2.91

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

223

1782

1.27

2.90

4.1

3.1

ng/l

191.7

214.5

0.43

199

1619

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

413

3534

1.20

2.83

2.8

3.0

e6/l

3.0

2.4

0.57

222

1951

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.77

2.81

1.4

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

148

1125

1.33

2.80

9.8

10.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1550

14615

1.13

2.77

4.7

4.4

e6/l

600.4

1666.1

0.99

204

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

297

2471

1.23

2.72

5.0

4.1

u/l

239.6

245.4

0.27

278

2340

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

617

1.44

2.71

1.4

1.6

g/l

0.2

0.17

583

(3009508) Creatinine [Moles/volume] in Urine

740

6657

1.15

2.71

3.6

3.3

mmol/l

7.5

7.8

0.72

606

5643

(3020491) Glucose [Moles/volume] in Blood

154

1.89

2.65

1.2

2.3

mmol/l

7.7

6.8

0.37

107

(3020682) Albumin/Creatinine [Ratio] in Urine

686

6147

1.15

2.65

4.1

mg/mmol

11.8

9.2

0.61

435

3955

(36660697) Celiac disease serology panel - Serum

232

1885

1.25

2.65

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

787

7125

1.14

2.62

3.3

mmol/l

2.3

2.4

0.21

680

6224

(3021788) Differential panel - Synovial fluid

376

1.55

2.62

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

319

2686

1.21

2.60

26.6

25.4

inr

1.3

1.4

0.40

388

(3022948) Iron [Moles/volume] in Serum or Plasma

399

3446

1.18

2.47

2.6

2.4

umol/l

12.8

13.1

0.48

373

3184

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

638

1.41

2.46

1.4

1.6

g/l

1.2

0.20

604

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

347

2963

1.19

2.45

2.8

2.5

22.3

22.9

0.30

285

2528

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

431

3750

1.18

2.44

2.7

2.8

e6/l

1.0

1.3

0.72

239

2158

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

159

1.83

2.43

2.8

2.6

e6/l

748.8

767.2

0.05

(3020779) Urea [Moles/volume] in Serum or Plasma

239

1969

1.23

2.43

9.2

7.7

mmol/l

10.3

9.4

1.16

230

1882

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

1.85

2.42

1.3

—

(3013512) EKG study

657

5905

1.15

2.42

4.1

3.8

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.01

2.40

2.5

1.4

mg/l

7.3

6.2

—

(40758558) Short blood count panel - Blood

625

5603

1.15

2.38

7.0

6.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

590

5272

1.15

2.36

1.4

1.3

u/ml

2.3

1.7

0.45

124

1344

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.51

2.35

2.2

—

(3023419) Bacteria identified in Sputum by Culture

267

1.62

2.35

3.1

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

300

2538

1.20

2.34

6.6

6.9

—

(3019060) Gas panel - Arterial blood

173

1384

1.27

2.29

5.1

5.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.62

2.27

2.5

1.5

mg/l

1.6

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

2.07

2.27

1.1

1.0

u/ml

13.8

10.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

117

891

1.33

2.25

2.2

2.0

u/l

40.3

38.9

0.32

103

797

(3039000) Anion gap in Blood

473

1.45

2.24

7.5

8.6

mmol/l

12.2

11.3

1.12

418

(3016502) Oxygen saturation in Arterial blood

254

2126

1.21

2.23

8.5

8.1

95.4

95.6

0.31

239

2040

(3018572) Chloride [Moles/volume] in Blood

474

1.45

2.22

7.5

8.6

mmol/l

105.9

105.3

0.52

419

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.05

2.21

3.6

3.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

551

1.41

2.19

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

380

3304

1.17

2.18

1.3

1.2

u/ml

12.7

11.3

0.13

121

1270

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

468

1.44

2.17

2.8

5.8

iu/ml

198.3

999.9

—

(40768797) Stomach Pathology biopsy report

333

2868

1.18

2.15

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

526

4697

1.15

2.12

2.4

1.8

mg/l

1.1

1.3

0.66

389

3515

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

136

1717

0.78

2.11

4.1

3.6

mmol/l

1.2

0.49

116

1468

(3002619) Bacteria identified in Specimen by Culture

2.45

2.10

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

268

1.58

2.09

2.6

2.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

382

3339

1.17

2.06

2.1

2.4

30.0

0.05

368

3230

(3002173) Hemoglobin [Mass/volume] in Arterial blood

233

1952

1.21

2.04

9.0

8.6

g/l

121.4

121.6

0.05

222

1872

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

238

1.60

2.04

1.6

1.5

60.4

61.7

0.07

151

(3012095) Magnesium [Moles/volume] in Serum or Plasma

396

3474

1.16

2.04

3.9

3.6

mmol/l

0.8

0.62

363

3239

(3000492) Spirometry study

248

2095

1.20

2.00

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1756

16850

1.11

1.97

4.0

3.9

pmol/l

14.7

0.19

1560

15247

(3003327) Ova and parasites identified in Stool by Light microscopy

103

788

1.32

1.96

1.6

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

187

1.66

1.94

1.7

1.5

promille

1.4

1.3

0.08

145

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.97

1.93

1.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

771

7093

1.12

1.93

3.4

3.2

u/l

31.8

32.9

0.35

731

6728

(3029937) Albumin [Presence] in Urine by Test strip

527

5840

0.88

1.92

4.2

3.9

estimate

0.0

1.08

140

2029

(3012516) Albumin [Mass/volume] in Urine

641

5837

1.13

1.91

3.5

3.3

mg/l

557.6

324.2

0.51

423

3788

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2079

20150

1.12

1.88

4.8

4.6

mu/l

2.5

2.0

0.39

1889

18477

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

106

820

1.30

1.87

1.7

1.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.86

1.86

1.1

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

100

769

1.31

1.85

1.3

1.2

u/ml

0.2

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

115

1.83

1.82

1.1

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

335

1.47

1.82

3.6

3.7

0.8

1.5

1.80

261

(3004616) Nuclear Ab [Presence] in Serum

254

1.54

1.81

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

215

1.59

1.79

2.9

3.5

56.1

56.0

0.01

141

(3018418) pH of Serum or Plasma

678

6217

1.12

1.79

4.0

3.9

7.4

0.13

1187

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

312

1.48

1.78

1.3

1.4

u/l

18.5

20.5

0.19

264

(3008757) Leukocyte morphology finding [Identifier] in Blood

248

1.54

1.76

3.2

3.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.09

1.76

1.0

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

124

1.78

1.75

1.5

1.4

umol/l

15.8

24.7

0.98

117

(4198724)

139

1.73

1.75

2.1

3.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

297

1.49

1.75

1.5

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

161

1323

1.23

1.75

1.8

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

457

1.39

1.72

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

263

2271

1.17

1.69

1.9

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

284

1.49

1.67

6.4

6.9

mg/l

10.8

11.7

0.44

261

(3000991) Gas panel - Venous blood

230

1968

1.18

1.65

9.9

8.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

778

8356

0.91

1.61

3.8

3.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1090

10290

1.10

1.60

4.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

708

1.29

1.58

2.6

2.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

568

1.33

1.58

1.2

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

1.71

1.56

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

237

2044

1.17

1.56

2.0

2.4

g/l

0.2

0.47

223

1906

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

150

1241

1.22

1.55

5.7

4.8

mmol/l

23.5

23.9

1.02

135

1140

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

192

2255

0.84

1.55

3.3

3.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2067

20103

1.10

1.55

3.8

3.7

mmol/l

1.3

1.62

1884

18423

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.28

1.53

2.5

3.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.34

1.52

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

3.34

1.52

9.4

4.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.83

1.51

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

715

1.28

1.49

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

531

1.33

1.48

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

847

7931

1.10

1.47

3.9

3.6

ng/l

129.4

55.1

0.44

521

5306

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

155

1.62

1.46

1.2

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.88

1.44

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.13

1.44

1.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

286

1.44

1.43

1.3

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

164

1.59

1.43

2.9

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

622

1.29

1.43

1.4

ug/g

274.2

291.3

0.32

347

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

658

0.72

1.42

1.6

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2113

20604

1.10

1.41

4.5

4.2

mmol/l

5.9

0.83

1920

18738

(3021387) Prolactin [Units/volume] in Serum or Plasma

939

0.77

1.40

1.5

1.6

mu/l

261.2

306.8

1.74

853

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.25

1.40

5.6

6.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.18

1.40

1.0

1.1

—

(3019977) pH of Arterial blood

111

1.72

1.39

2.2

2.4

7.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

364

1.38

1.1

iu/ml

50.6

1387.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

511

1.32

1.38

1.6

1.9

iu/l

4.4

5.1

0.29

184

(3003694) ABO and Rh group [Type] in Blood

600

6481

0.91

1.38

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.00

1.38

2.2

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2190

21400

1.10

1.38

4.7

4.5

mmol/l

2.7

1.63

2006

19713

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

324

0.61

1.38

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

119

1.69

1.37

1.5

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

554

6007

0.90

1.37

3.3

3.2

—

(3000034) Microalbumin [Mass/volume] in Urine

174

1.56

1.37

3.0

3.4

mg/l

21.3

33.6

0.44

134

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.80

1.37

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.80

1.37

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.20

1.37

1.4

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

122

1004

1.22

1.36

1.8

g/l

1.5

0.03

106

874

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

540

1.30

1.34

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.92

1.33

2.8

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2290

22441

1.10

1.31

18.2

15.8

mmol/l

139.6

0.23

2222

21808

(3023430) Cat dander IgE Ab [Units/volume] in Serum

343

1.38

1.30

1.1

u/ml

4.8

8.3

0.81

150

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

526

1.30

1.29

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

422

1.33

1.27

1.3

1.2

u/ml

3.7

4.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2294

22495

1.10

1.26

18.4

15.9

mmol/l

4.0

0.13

2215

21820

(3014599) Egg white IgE Ab [Units/volume] in Serum

162

1.55

1.25

1.2

u/ml

9.8

4.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

107

1.69

1.25

1.3

1.4

mmol/l

6.0

5.9

0.08

102

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

320

1.38

1.25

1.5

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

542

5007

1.10

1.24

3.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.86

1.23

1.4

1.2

112.5

109.5

0.12

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2132

20846

1.09

1.22

4.3

4.1

mmol/l

1.4

5.89

1949

19216

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

108

1.67

1.22

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

436

3989

1.11

1.21

1.8

nmol/l

1134.4

1160.4

0.23

318

2987

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

279

2488

1.13

1.21

2.4

2.8

umol/l

7.7

8.4

0.26

237

2146

(3026008) Bacteria identified in Urine by Culture

702

6573

1.09

1.21

3.3

3.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

124

1.62

1.20

1.1

ratio

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

142

0.49

1.20

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

109

1.66

1.18

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

152

1302

1.18

1.15

7.3

mmol/l

24.3

24.5

0.28

141

1206

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.73

1.15

2.1

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.73

1.15

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.73

1.15

2.1

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

158

1.52

1.14

1.2

—

62.2

—

(4146454)

199

1.46

1.14

3.1

2.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

537

1.27

1.13

1.3

1.2

u/ml

8.7

14.9

—

(44806071)

2.34

1.12

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

379

1.32

1.12

1.1

u/ml

7.2

5.8

0.13

154

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.00

1.12

1.5

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

529

1.27

1.12

1.3

1.2

u/ml

8.0

2.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

119

1.60

1.11

1.5

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

515

0.73

1.10

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

104

1.64

1.09

2.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.95

1.08

1.9

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

496

1.28

1.08

1.6

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

386

0.70

1.08

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.69

1.07

2.1

1.6

—

(3005033) Fetal Nuchal fold Thickness US

512

0.74

1.07

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

650

1.24

1.06

1.4

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

600

0.76

1.04

1.8

1.7

—

(3018095) Leukocytes [#/volume] in Urine

826

7831

1.08

1.04

3.9

3.7

e6/l

59.2

99.4

1.45

590

5557

(3008037) Lactate [Moles/volume] in Venous blood

452

0.73

1.04

4.2

3.1

mmol/l

1.6

0.02

437

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.96

1.03

1.4

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

709

6686

1.08

1.03

3.4

3.3

e6/l

40.1

78.3

1.75

547

5180

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.06

1.03

3.4

1.8

pmol/l

93.0

24.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

109

918

1.19

1.02

2.0

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.02

1.1

—

(3045424) Erythrocytes [Presence] in Urine

333

1.33

1.02

1.2

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

176

2001

0.87

1.01

2.2

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

381

3499

1.10

1.01

2.2

2.3

—

(4306422)

299

1.34

1.00

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

147

1.50

1.00

1.2

—

28.5

—

(3032057) Clostridioides difficile [Presence] in Stool

1.88

1.00

1.6

2.0

—

(3002385) Erythrocyte distribution width [Ratio]

1843

18870

0.93

1.00

19.7

16.6

13.8

13.6

3.65

1806

18442

(3001556) Androgen free Index in Serum or Plasma

2.00

1.00

1.0

1.1

—

(3002256) Pathology report gross observation

296

2686

1.11

0.99

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

638

1.23

0.99

1.7

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

164

1.47

0.99

1.3

u/ml

1.3

0.00

(3043238) Trisomy 21 risk [Likelihood] in Fetus

527

0.76

0.99

1.6

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

156

1.48

0.98

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.48

0.98

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.48

0.98

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.48

0.98

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.48

0.98

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

175

1985

0.87

0.98

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1.47

0.96

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

216

1.39

0.95

4.2

3.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.95

0.0

2.3

—

(3002032) Base excess in Venous blood by calculation

242

2179

1.12

0.94

5.5

4.3

mmol/l

1.7

1.8

0.12

188

1733

(3005011) Chlamydia sp Ab [Titer] in Serum

1.89

0.94

1.7

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

249

2754

0.89

0.93

1.6

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.22

0.93

2.0

7.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

234

1.37

0.93

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

717

1.21

0.92

5.2

4.2

u/ml

0.3

0.4

1.21

407

(3044941) Cell count panel - Synovial fluid

339

1.30

0.92

1.7

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2142

21030

1.07

0.92

4.3

4.1

mmol/l

4.5

4.6

4.57

1968

19487

(3019150) Specific gravity of Urine by Refractometry

511

4781

1.08

0.91

3.8

4.0

kg/l

1.0

0.58

719

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

176

1.42

0.90

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

143

1628

0.87

2.1

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

369

1.28

0.87

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

668

1.20

0.86

1.3

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.82

0.85

5.4

3.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

936

1.17

0.85

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

379

0.74

0.85

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

311

2856

1.10

0.85

1.9

1.8

1.5

0.17

275

2531

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

112

1.52

0.84

1.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

112

1.52

0.84

1.9

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

112

1.52

0.84

1.9

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

112

1.52

0.84

1.9

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

256

1.33

0.84

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.94

0.84

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

524

0.78

0.84

4.0

4.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

624

1.21

0.84

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

422

0.76

0.83

4.3

3.2

mmol/l

7.2

7.6

0.42

409

(1617658) Protocol used for examination of sentinel lymph nodes

141

0.57

0.82

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.74

0.82

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

115

0.52

0.82

2.5

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

351

3787

0.92

0.82

3.0

ug/l

1.0

0.8

0.97

246

2483

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

112

1290

0.86

0.81

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

664

1.20

0.80

7.7

6.0

mg/l

1.5

1.4

0.34

612

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

150

1327

1.14

0.80

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

114

989

1.16

0.80

1.2

1.1

—

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

491

1.23

0.80

2.3

2.1

g/l

128.4

130.2

0.21

362

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

546

1.21

0.79

1.2

1.1

u/ml

1.1

2.5

0.88

254

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2062

20258

1.06

0.79

14.1

12.7

ml/min/173m2

83.6

0.00

1672

16503

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.79

0.0

7.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.79

0.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.78

0.0

2.6

—

0.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2384

23538

1.08

0.78

11.0

9.8

u/l

26.5

26.3

0.12

2293

22681

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.59

0.78

1.3

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.77

0.0

7.3

—

19.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.77

0.0

1.3

—

819.7

—

(4035726)

194

1749

1.12

0.77

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.64

0.75

1.8

—

(36304419) Bacteria [Presence] in Urine

632

6013

1.07

0.72

3.3

3.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

0.72

1.4

2.0

umol/l

62.4

43.4

—

(4281824)

195

0.67

0.72

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.67

0.72

1.6

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

471

1.21

0.71

1.1

u/ml

2.2

3.9

0.61

127

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.75

0.71

1.0

1.2

—

(3022145) Colonoscopy Study observation

249

2287

1.10

0.71

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

300

1.27

0.70

1.4

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

363

1.24

0.70

3.8

5.2

umol/l

401.0

368.6

0.95

321

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

647

1.18

0.70

1.5

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1028

0.86

0.70

1.4

1.5

iu/l

18.3

22.0

0.57

849

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.85

0.68

1.2

2.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

127

1.42

0.68

1.8

2.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

127

1.42

0.68

1.2

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

127

1.42

0.68

1.2

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

473

0.80

0.66

3.3

2.3

16.9

16.3

0.48

232

(3000850) Epithelial cells [#/volume] in Urine

492

4660

1.07

0.66

2.7

2.6

e6/l

5.7

5.9

0.14

431

4113

(3008898) HLA-B27 [Presence]

801

1.15

0.65

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

644

1.17

0.64

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1591

15569

1.05

0.64

3.4

3.2

—

(40768795) Lymph node Pathology biopsy report

189

0.69

0.63

1.4

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

387

1.22

0.63

1.7

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

104

1.44

0.62

2.1

2.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

104

1.44

0.62

1.3

2.9

umol/l

172.6

144.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

311

2905

1.08

0.62

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

225

2074

1.09

0.61

2.2

2.5

u/l

28.4

38.8

3.13

192

1777

(3021447) Carbon dioxide [Partial pressure] in Venous blood

237

2190

1.09

0.61

5.7

4.3

kpa

5.9

5.8

0.60

232

2126

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.67

0.61

3.8

8.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

122

1362

0.89

0.60

1.3

1.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

2.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

254

1.26

0.59

1.3

1.2

—

43.3

—

(4212803)

0.00

0.59

0.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

0.59

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

288

0.76

0.59

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

1.45

0.59

3.7

3.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

227

2099

1.09

0.58

2.1

2.2

nmol/l

373.1

369.4

0.10

207

1922

(3001019) Free T4 and TSH panel - Serum or Plasma

1117

0.88

0.58

1.8

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

170

1551

1.10

0.58

1.8

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

343

0.79

0.58

1.6

1.5

nmol/l

0.2

0.4

1.86

284

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

810

1.14

0.58

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

178

1629

1.10

0.58

4.0

3.9

0.5

0.6

0.43

354

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

669

0.85

0.57

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

342

3218

1.07

0.57

2.1

2.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

132

1.37

0.57

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

310

1.23

0.57

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

229

1.27

0.56

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.46

0.56

1.1

—

(3022621) pH of Urine by Test strip

156

1423

1.10

0.55

3.2

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

504

5277

0.95

0.54

4.4

4.3

22.0

21.7

0.14

240

2496

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

711

1.14

0.54

2.5

3.1

g/l

3.5

0.05

677

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

142

1.34

0.54

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

472

4949

0.94

0.54

5.2

4.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.42

0.54

1.1

2.1

185.8

136.2

1.52

(3000093) Morphology [Interpretation] in Blood Narrative

213

1.27

0.54

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

506

1.17

0.53

1.1

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

703

1.14

0.53

5.8

4.7

kpa

9.0

8.7

0.71

660

(3014148) Varicella zoster virus Ab [Titer] in Serum

322

1.21

0.53

1.1

1.2

—

(4211845)

108

1.39

0.53

3.6

3.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

350

1.20

0.52

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

836

1.13

0.52

6.5

6.0

0.9

0.51

774

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.52

0.52

2.3

2.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

407

3866

1.06

0.52

2.8

3.0

mmol/l

2.5

2.4

0.21

357

3386

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.43

0.52

1.4

2.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.43

0.52

1.3

1.4

mmol/l

4.0

3.4

—

(3048689) Calprotectin [Mass/mass] in Stool

310

2921

1.07

0.51

2.3

2.6

ug/g

175.1

128.0

0.99

241

2305

(44813793)

157

0.70

0.51

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

195

1807

1.08

0.50

2.2

2.4

ug/l

7.0

6.9

0.01

166

1598

(3009542) Hematocrit [Volume Fraction] of Blood

2127

21017

1.05

0.50

17.8

14.6

40.1

39.9

0.31

1561

15463

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

325

1.20

0.49

1.1

u/ml

0.0

0.5

—

(3030467) Casts [#/volume] in Urine by Automated count

637

6137

1.05

0.49

3.4

3.2

e6/l

0.3

0.4

2.09

484

4684

(3035941) MCH [Entitic mass]

2536

25175

1.07

0.49

22.7

19.8

30.1

30.2

0.47

2500

24779

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

344

1.19

0.49

1.2

u/l

90.4

45.7

0.35

295

(3010813) Leukocytes [#/volume] in Blood

2537

25187

1.06

0.48

22.9

19.9

e9/l

7.0

6.8

2.87

2464

24423

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.52

0.48

1.0

1.2

u/ml

2.1

6.8

—

(3028433) Virus identified in Specimen by Culture

1.45

0.48

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

484

1.16

0.48

2.7

2.4

ug/min

52.8

92.9

0.92

298

(3026361) Erythrocytes [#/volume] in Blood

2536

25178

1.06

0.48

22.8

19.9

e12/l

4.5

0.23

2465

24422

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1035

10085

1.04

0.48

3.1

2.8

ug/l

117.0

116.0

0.05

951

9324

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

494

1.16

0.47

1.2

—

(44806118)

263

1.22

0.47

1.5

1.6

—

(44790049)

263

1.22

0.47

1.5

1.6

—

(44790048)

263

1.22

0.47

1.5

1.6

—

(44790047)

263

1.22

0.47

1.5

1.6

—

(3007461) Platelets [#/volume] in Blood

2533

25151

1.06

0.46

22.9

19.9

e9/l

252.9

250.6

1.02

2474

24457

(3020874) Milk IgE Ab [Units/volume] in Serum

164

1.28

0.46

1.0

1.2

u/ml

0.9

3.0

—

(3017181) Myelocytes/100 leukocytes in Blood

192

1786

1.08

0.46

4.3

4.0

0.8

0.9

0.23

491

(40761511) CBC panel - Blood by Automated count

2354

23329

1.05

0.46

14.6

12.8

—

(3024731) MCV [Entitic volume]

2535

25173

1.06

0.46

22.8

19.8

90.5

0.01

2501

24780

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.60

0.45

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

412

1.17

0.45

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

154

1421

1.09

0.45

2.5

2.4

au/ml

33.1

22.9

—

(40768443) Skin Pathology biopsy report

865

1.11

0.45

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

138

1.31

0.45

1.6

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.59

0.45

1.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

1073

0.90

0.45

3.9

3.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

174

1.27

0.44

1.6

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

413

1.16

0.44

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

563

1.14

0.44

4.5

3.1

mmol/l

24.7

24.8

0.12

486

(3000963) Hemoglobin [Mass/volume] in Blood

2536

25189

1.06

0.44

23.0

20.0

g/l

135.2

135.5

0.52

2501

24797

(3017446) Testosterone [Moles/volume] in Serum or Plasma

189

1762

1.08

0.44

1.9

2.2

nmol/l

12.1

12.7

0.43

160

1566

(4027681)

157

1.28

0.43

1.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

312

1.19

0.43

1.1

1.2

u/ml

3.1

4.7

0.38

138

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

508

1.14

0.43

1.5

—

(4024509)

185

0.76

0.43

1.3

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

131

0.69

0.43

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.61

0.43

1.0

1.1

—

(40768793) Breast Pathology biopsy report

436

0.85

0.43

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

424

1.16

0.43

1.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

203

2166

0.93

0.42

1.3

—

(3024928) Oxygen saturation in Venous blood

471

1.15

0.42

6.0

3.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

359

1.17

0.42

4.2

3.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

221

1.22

0.42

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

784

1.11

0.42

1.3

miu/ml

200.8

227.5

0.31

364

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

0.72

0.42

1.0

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

425

1.16

0.42

1.3

1.2

u/ml

93.1

39.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

270

2555

1.06

0.41

2.8

2.7

1.7

0.01

225

2253

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

176

1.25

0.41

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

842

1.11

0.41

6.5

5.9

1.9

1.6

1.16

779

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

1.2

—

(3024316) Viscosity of Plasma

0.00

0.41

0.0

1.5

—

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.36

0.41

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

558

1.13

0.40

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

250

1.20

0.40

1.6

2.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

782

0.89

0.40

1.4

1.6

u/l

10.3

8.3

0.49

621

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.40

0.0

3.7

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

334

1.17

0.39

1.2

1.1

u/ml

4.3

2.3

—

156

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.43

0.39

1.0

1.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.39

0.0

1.2

—

27.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

106

1.32

0.39

1.4

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

251

1.20

0.39

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

428

1.15

0.39

2.2

3.3

nmol/l

0.8

0.06

331

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

258

0.81

0.38

1.8

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.35

0.37

1.2

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

439

1.14

0.37

3.3

e9/l

4.2

4.1

0.04

439

(3014765) Yersinia sp identified in Stool by Organism specific culture

676

1.11

0.37

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

179

1.23

0.37

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

179

1.23

0.37

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

179

1.23

0.37

1.8

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.35

0.37

1.0

1.1

—

(40761535) Cells panel - Urine sediment

163

1741

0.93

0.37

3.4

3.5

—

(3037756) Immunofixation for Serum or Plasma

421

1.14

0.36

1.2

1.6

—

(3045414) Leukocytes [Presence] in Urine

103

946

1.09

0.36

2.2

1.9

—

(3035285) Chloride [Moles/volume] in Venous blood

267

0.82

0.36

3.0

2.5

mmol/l

106.4

105.2

0.67

262

(3041354) Potassium [Moles/volume] in Venous blood

267

0.82

0.36

3.0

2.5

mmol/l

4.0

4.1

1.02

262

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.27

0.36

1.0

—

(3011648) Oxygen content in Venous blood

189

1.22

0.36

4.7

4.9

13.3

11.1

1.30

189

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

300

1.17

0.36

1.5

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

196

1848

1.06

0.35

2.8

2.7

e9/l

72.9

69.6

0.44

142

1387

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

319

1.16

0.35

1.5

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

631

1.11

0.35

1.2

1.1

u/ml

17.4

4.7

—

(3036489) Thrombin time

861

1.09

0.35

2.3

2.6

21.1

21.7

0.67

765

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

108

1.30

0.35

4.4

3.0

u/ml

812.5

1258.5

0.70

108

(3045462) Protein/Creatinine [Ratio] in Urine

1.40

0.35

8.0

5.2

g/mol

66.6

53.3

—

(3022689) Creatine [Moles/volume] in Urine

1.36

0.34

1.2

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.36

0.34

3.5

8.0

—

(3015736) pH of Urine

863

8435

1.03

0.34

3.4

—

5.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

154

1.24

0.33

1.6

1.4

u/l

13.0

13.8

0.24

145

(3021440) Promyelocytes/100 leukocytes in Blood

180

1697

1.06

0.33

4.5

4.1

0.1

0.28

450

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

453

1.13

0.33

1.6

2.2

nmol/l

1.0

0.8

1.22

382

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

453

1.13

0.33

4.1

3.6

58.9

57.6

0.38

453

(3014111) Lactate [Moles/volume] in Serum or Plasma

200

1893

1.06

0.33

9.0

7.2

mmol/l

1.3

1.4

0.58

194

1821

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

182

1.21

0.33

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

683

1.10

0.32

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

369

1.14

0.32

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.33

0.32

1.1

1.2

u/ml

0.9

8.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

351

1.14

0.31

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

194

1838

1.06

0.31

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

138

1293

1.07

0.31

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

146

1372

1.07

0.31

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

110

1023

1.08

0.31

4.4

3.1

1.5

1.2

1.62

110

1015

(3045142) Bone marrow Pathology biopsy report

249

1.17

0.30

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.31

0.30

1.1

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

572

1.10

0.30

4.8

3.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

832

1.08

0.29

2.2

1.9

ug/l

1.4

1.7

0.13

729

(40768806) Pleura Pathology biopsy report

222

1.17

0.29

1.4

1.5

—

(3044889) 12 lead EKG panel

1451

14695

0.97

0.29

3.8

3.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

115

1076

1.07

0.28

2.6

2.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

259

0.85

0.28

3.0

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

137

1291

1.06

0.28

1.1

—

(3011288) Drugs identified in Urine by Screen method

894

1.08

0.27

4.8

3.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

672

1.09

0.27

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

469

0.89

0.27

1.6

1.8

pmol/l

205.8

204.2

0.02

447

(3049717) Cytology report of Urine Cyto stain

817

1.08

0.27

3.0

2.6

—

(4094501)

500

0.90

0.27

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

721

1.08

0.26

2.2

3.4

u/ml

1448.2

5475.5

0.50

615

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

262

1.15

0.26

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

319

1.13

0.26

1.2

u/ml

1.2

3.6

1.61

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.19

0.26

2.1

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.19

0.26

2.1

2.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

454

1.10

0.25

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

531

1.09

0.25

1.2

1.3

u/ml

212.0

234.9

0.39

307

(3044290) Cell count panel - Cerebral spinal fluid

483

1.10

0.25

1.4

1.8

—

(3020891) Body temperature

839

0.93

0.24

5.3

4.4

—

(3042733) HLA Ab [Presence] in Serum

1.17

0.24

3.7

4.5

—

(3024932) HLA-DR beta [Type]

0.73

0.24

1.0

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

176

1681

1.05

0.24

1.9

2.6

g/l

66.8

66.5

0.23

161

1529

(3024471) HLA-A [Type]

0.71

0.24

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

211

0.85

0.23

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.28

0.23

1.4

1.6

ug/l

0.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

156

1634

0.95

0.22

3.3

2.7

ml/min/173m2

66.8

66.7

0.01

656

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

200

0.85

0.22

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

181

1.16

0.22

1.2

1.5

—

(3025159) Blasts/100 leukocytes in Blood

167

1597

1.05

0.22

4.4

4.2

0.1

0.5

0.80

377

(3026782) Osmolality of Urine

450

4389

1.03

0.22

3.0

2.8

mosm/kgh2o

558.5

553.7

0.17

381

3750

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.22

0.22

1.2

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.22

0.22

2.0

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

167

0.84

0.21

1.2

—

(3010421) pH of Blood

606

0.92

0.21

5.1

4.1

7.4

0.41

502

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

0.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

0.8

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.1

—

4575.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

1.2

—

0.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

3.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

469

1.09

0.21

1.5

u/ml

101.7

105.7

—

(3020393) Adenovirus Ag [Presence] in Stool

1.16

0.21

1.6

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

0.83

0.21

1.1

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.8

—

4.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

15.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

1.17

0.20

1.1

1.2

—

(3001729) Color of Synovial fluid

0.00

0.20

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

40.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.25

0.20

3.5

7.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

355

0.90

0.20

1.4

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.22

0.20

1.5

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.22

0.19

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

154

0.84

0.19

1.1

2.2

—

(3012501) Base excess in Blood by calculation

509

0.92

0.19

5.4

4.4

mmol/l

2.2

2.5

0.41

331

(3034274) Bile acid [Moles/volume] in Serum --fasting

337

1.10

0.19

1.8

2.4

umol/l

3.5

9.5

2.69

257

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

156

1.15

0.18

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

784

1.06

0.18

1.3

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.19

0.18

1.4

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.19

0.18

3.1

2.4

mmol/l

1.4

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

1066

10777

0.98

0.17

5.0

4.9

estimate

0.0

0.50

149

2106

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

104

992

1.05

0.17

4.5

3.1

0.7

0.6

0.18

951

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.11

0.17

1.1

—

(44806420)

1.11

0.17

2.3

2.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

485

1.07

0.16

1.1

u/ml

0.5

1.7

1.62

233

(40760888) Immunoglobulin light chains.free panel - Serum

464

0.93

0.16

1.8

3.6

—

(3034426) Prothrombin time (PT)

1.18

0.16

1.0

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

618

0.94

0.16

1.7

3.4

ratio

1.3

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

1.16

0.16

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

225

0.89

0.16

1.9

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

244

1.11

0.16

1.4

1.5

pmol/l

332.6

341.8

0.04

185

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

847

1.05

0.16

1.9

1.7

mg/l

3.7

4.3

0.18

590

(42870560) Thyrotropin [Units/volume] in Cord blood

1.11

0.16

1.0

mu/l

6.4

8.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

206

1.12

0.16

1.3

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

506

1.07

0.15

1.1

u/ml

3.9

6.5

0.74

287

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.10

0.15

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

121

1162

1.04

0.15

1.2

1.1

titre

113.9

145.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

477

1.07

0.15

2.1

3.0

umol/l

33.7

34.0

0.04

404

(3015183) Erythrocyte sedimentation rate

119

0.84

0.15

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

114

1094

1.04

0.15

2.6

2.3

u/l

2192.3

5374.8

1.63

399

(3017704) Immunofixation for Urine

121

1.16

0.15

1.2

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

671

6618

1.02

0.14

4.7

4.9

ug/l

2.9

3.7

0.42

580

5911

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

169

1.12

0.14

1.1

1.3

pmol/l

17.5

64.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

275

1.09

0.14

1.2

1.4

mmol/l

6.6

7.2

1.01

194

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

141

1.14

0.13

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

141

1.14

0.13

1.1

1.0

—

(3004451) EKG impression Narrative

103

1.17

0.13

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

402

1.07

0.13

3.3

3.6

u/ml

2360.8

991.9

0.30

376

(3035350) Ketones [Presence] in Urine by Test strip

1068

10775

0.99

0.13

3.7

3.6

estimate

0.0

0.80

140

2075

(3025941) Bacteria identified in Stool by Culture

132

1276

1.04

0.13

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.17

0.13

1.0

—

(3003338) MCHC [Mass/volume]

1954

19451

1.01

0.12

20.5

17.4

g/l

332.5

333.0

1.45

1943

19269

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

570

1.05

0.12

2.5

2.2

mg/l

10.7

11.3

0.15

526

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

104

1.15

0.12

1.1

iu/ml

422.6

209.9

0.59

104

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

116

0.86

0.12

6.6

6.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

522

5289

0.98

0.11

1.7

1.6

mmol/l

1.4

0.06

439

4475

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

220

1.09

0.11

1.1

—

(40768800) Prostate Pathology biopsy report

394

0.94

0.11

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

260

1.08

0.10

3.1

2.8

nmol/l

18.4

20.4

0.56

247

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

1.10

0.10

1.0

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

115

1.13

0.10

1.2

1.3

—

71.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

495

1.05

0.10

3.0

3.4

mg/l

30.2

27.2

0.17

318

(3032773) Endomysium IgG Ab [Titer] in Serum

202

1.09

0.10

1.2

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

633

1.04

0.10

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.14

0.10

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.14

0.10

1.6

1.9

nmol/l

2.4

4.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.14

0.10

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.14

0.10

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

151

1547

0.97

0.10

1.3

1.2

iu/ml

170.4

138.6

0.45

585

(3024263) Appearance of Synovial fluid

106

1.13

0.09

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

634

1.04

0.09

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

164

1.10

0.09

1.0

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

1.10

0.09

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

635

1.04

0.09

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

635

1.04

0.09

1.4

—

(3037121) Protein [Mass/volume] in Urine

803

1.03

0.09

3.1

3.5

g/l

0.3

0.24

351

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

155

1.10

0.09

1.4

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.81

0.08

1.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

156

1.09

0.08

1.1

1.3

mmol/l

32.6

36.2

0.30

141

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

127

1.10

0.07

1.6

1.5

u/l

16.6

7.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

186

1827

1.02

0.07

5.1

3.8

kpa

5.1

4.7

1.37

181

1773

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.83

0.07

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.83

0.07

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.81

0.07

1.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

327

0.95

0.07

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

718

1.03

0.07

1.6

iu/ml

0.2

8.6

0.50

143

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.03

0.07

1.3

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.83

0.07

1.0

1.2

—

0.1

—

(3035880) pH of Pleural fluid

118

1.10

0.07

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.05

0.07

1.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

206

1.07

0.07

2.8

2.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.02

0.07

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.86

0.06

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

503

4987

1.01

0.06

1.8

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

128

1.09

0.06

3.6

2.8

39.5

42.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

650

1.03

0.06

1.5

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

132

0.91

0.06

1.5

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

138

1.09

0.06

1.1

u/l

0.9

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

364

1.04

0.06

1.5

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

104

0.86

0.06

2.7

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

104

0.86

0.06

5.3

5.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

760

1.03

0.06

2.4

2.3

ug/l

1408.1

484.0

0.43

711

(3009261) Glucose [Presence] in Urine by Test strip

1084

10887

0.99

0.06

3.7

3.6

estimate

0.0

1.32

141

2048

(21494434) Karyotype in Bone marrow

213

0.94

0.06

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

243

0.95

0.05

1.7

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

637

0.97

0.05

1.7

3.4

mg/l

35.3

80.8

1.30

523

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

198

1.06

0.05

1.3

1.2

u/l

64.2

86.0

0.50

141

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

100

1.10

0.05

1.1

miu/ml

1403.7

1555.6

0.15

100

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

252

0.95

0.05

1.2

1.3

nmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

353

0.96

0.04

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

393

3958

0.99

0.04

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

282

0.96

0.04

2.7

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

635

0.98

0.04

1.7

3.4

mg/l

41.7

59.7

0.95

520

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

202

1998

1.01

0.04

3.7

4.2

ug/l

16.0

17.5

0.06

153

1632

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

150

0.93

0.04

1.5

1.6

—

(40768446) Kidney Pathology biopsy report

1.10

0.04

2.4

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

445

4477

0.99

0.04

1.7

pmol/l

14731289.1

25852777.1

0.30

353

3725

(3012565) Volume of 24 hour Urine

101

1.09

0.04

2.2

2.5

1845.5

1993.3

0.22

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

259

1.04

0.04

1.1

1.3

—

(4034850)

664

0.98

0.04

14.2

10.1

—

(1002224) Polysomnography panel

825

1.02

0.04

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

533

0.98

0.04

1.5

1.8

e6/l

1343.4

859.4

0.26

431

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

533

0.98

0.04

1.5

1.8

e6/l

50.0

14.9

0.37

414

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

121

1.07

0.03

1.2

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

562

0.98

0.03

1.4

2.4

g/l

0.0

0.00

515

(3025130) Human papilloma virus identified in Specimen

260

1.04

0.03

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

139

1375

1.01

0.03

1.6

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

692

0.98

0.03

1.4

1.5

—

(1616796) Gas panel - Central venous blood

489

1.02

0.03

5.4

3.7

—

(3006653) Thiamine [Moles/volume] in Blood

108

0.93

0.03

1.0

1.3

nmol/l

145.9

138.5

—

108

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

728

1.02

0.03

1.5

2.5

g/l

3.0

3.1

0.61

583

(3027944) Amphetamines [Presence] in Urine

130

1312

0.99

0.02

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

188

0.96

0.02

1.3

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

590

1.02

0.02

1.4

2.4

g/l

0.0

1.09

541

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

198

0.96

0.02

1.5

1.6

mmol/l

7.5

7.4

0.02

115

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

670

1.02

0.02

1.4

2.5

g/l

0.9

1.1

0.34

580

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

267

2683

0.99

0.02

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

125

1239

1.01

0.02

3.6

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

262

1.03

0.02

1.6

1.4

e6/l

1263.4

1683.2

0.58

190

(1001926) Buprenorphine [Presence] in Urine by Screen method

105

1040

1.01

0.01

3.8

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

779

0.99

0.01

1.5

2.4

g/l

3.9

3.8

0.15

572

(3021901) Oxygen saturation in Capillary blood

412

1.02

0.01

3.9

2.7

—

(40768441) Liver Pathology biopsy report

157

0.96

0.01

1.1

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

508

0.98

0.01

3.1

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

357

0.98

0.01

1.6

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

104

1.06

0.01

28.8

4.9

mg/l

54.5

72.9

—

(3028300) Cannabinoids [Presence] in Urine

133

1337

0.99

0.00

3.5

2.4

—

(3045788) Cell count panel - Pleural fluid

204

1.03

0.00

1.8

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

556

0.99

0.00

1.4

2.4

g/l

0.0

0.00

514

(3000012) Reticulocyte production index

105

1.05

0.00

2.5

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

102

0.98

0.00

3.8

3.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

234

0.98

0.00

1.7

1.4

e6/l

20107.8

87162.2

1.34

135

(3051593) INR in Capillary blood by Coagulation assay

1.05

0.00

5.0

13.1

—

(3012441) Differential panel - Pleural fluid

219

1.00

0.00

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

166

1.02

0.00

1.1

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

156

1.03

0.00

3.0

1.7

—

(3027008) Opiates [Presence] in Urine

133

1334

1.00

0.00

3.5

2.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

284

0.99

0.00

1.2

1.3

nmol/l

0.6

0.48

271

(3050129) First trimester maternal screen panel - Serum or Plasma

836

1.00

0.00

1.6

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.01

0.00

1.3

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

106

1.04

0.00

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

181

0.99

0.00

1.6

1.4

37.8

29.8

0.37

111

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

178

1.01

0.00

1.8

3.5

—

(3021589) Normoblasts [#/volume] in Blood

993

9925

1.00

0.00

9.6

9.3

e9/l

0.0

0.00

786

8067

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

155

1.03

0.00

17.8

13.4

nmol/l

705.8

786.5

0.28

149

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

263

0.99

0.00

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

622

1.00

0.00

1.4

2.3

g/l

38.1

37.5

0.26

538

(3000764) Benzodiazepines [Presence] in Urine

133

1325

1.00

0.00

3.5

2.4

—

(4268621)

212

0.99

0.00

2.2

2.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

740

1.00

0.00

1.5

2.4

g/l

9.8

10.3

0.79

628

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

329

3285

1.00

0.00

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

113

0.97

0.00

4.5

1.3

u/l

178.2

348.2

0.75

101

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

113

0.97

0.00

1.5

1.1

u/l

21.5

17.4

0.22

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

235

1.02

0.00

1.3

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

121

0.99

0.00

1.5

1.1

u/l

69.7

85.8

0.41

107

(3044927) Protein electrophoresis panel - Urine

220

1.00

0.00

1.2

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

779

1.00

0.00

1.5

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

779

1.00

0.00

1.5

2.4

g/l

7.1

7.4

0.89

591

(3003181) Sodium [Moles/volume] in Urine

392

0.99

0.00

1.4

mmol/l

61.6

65.3

0.19

319

(3008295) Osmolality of Serum or Plasma

253

0.99

0.00

1.6

1.5

mosm/kgh2o

289.0

282.1

0.67

184

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

104

0.96

0.00

1.1

u/l

89.1

22.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

104

0.96

0.00

1.1

u/l

190.8

82.4

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.86

0.00

1.0

kpa

6.9

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.6

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.7

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

2.4

—

1.5

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.7

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.86

0.00

1.0

—

0.5

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3006598) pH of Arterial cord blood

0.86

0.00

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.7

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1745.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.86

0.00

1.0

kpa

3.4

3.3

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.01

0.00

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

0.92

0.00

2.3

2.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.01

0.00

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.99

0.00

1.6

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

0.00

1.8

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.97

0.00

1.5

1.3

ug/l

7.4

9.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.96

0.00

2.2

2.3

umol/l

17.0

16.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.9

—

1044.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_CHRON_SUPOTITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_CHRON_SUPOTITIS	1.218 [1.07, 1.39]	0.003
Birth year	0.994 [0.99, 1.0]	0.171

During the follow-up period (1.1.1998 — 31.12.2019), 566 out of 6742 females with H8_CHRON_SUPOTITIS died.

Males

Parameter	HR [95% CI]	p-value
H8_CHRON_SUPOTITIS	1.217 [1.06, 1.4]	0.006
Birth year	0.985 [0.98, 0.99]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 673 out of 8885 males with H8_CHRON_SUPOTITIS died.

Mortality risk

Mortality risk for people of age

years, who have H8_CHRON_SUPOTITIS.

N-year risk	Females	Males
1	0.116%	0.167%
5	0.661%	1.295%
10	1.752%	3.212%
15	3.385%	6.503%
20	6.301%	10.844%

Relationships between endpoints

↥

Index endpoint: H8_CHRON_SUPOTITIS – Chronic suppurative otitis media

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chronic suppurative otitis media

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints